Complement alternative pathway activation in human nonalcoholic steatohepatitis.
about
Immunology in the liver--from homeostasis to disease.Identification of Pathways in Liver Repair Potentially Targeted by Secretory Proteins from Human Mesenchymal Stem Cells.Complement C3 and fatty liver disease in Rheumatoid arthritis patients: a cross-sectional study.Complement Factor D protects mice from ethanol-induced inflammation and liver injury.Complement Activation in Liver Transplantation: Role of Donor Macrosteatosis and Implications in Delayed Graft Function.
P2860
Complement alternative pathway activation in human nonalcoholic steatohepatitis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Complement alternative pathway activation in human nonalcoholic steatohepatitis.
@ast
Complement alternative pathway activation in human nonalcoholic steatohepatitis.
@en
Complement alternative pathway activation in human nonalcoholic steatohepatitis.
@nl
type
label
Complement alternative pathway activation in human nonalcoholic steatohepatitis.
@ast
Complement alternative pathway activation in human nonalcoholic steatohepatitis.
@en
Complement alternative pathway activation in human nonalcoholic steatohepatitis.
@nl
prefLabel
Complement alternative pathway activation in human nonalcoholic steatohepatitis.
@ast
Complement alternative pathway activation in human nonalcoholic steatohepatitis.
@en
Complement alternative pathway activation in human nonalcoholic steatohepatitis.
@nl
P2093
P2860
P1433
P1476
Complement alternative pathway activation in human nonalcoholic steatohepatitis.
@en
P2093
Ann Driessen
Bas Boonen
Charlotte de Jonge
Filip M Segers
Froukje J Verdam
Jan Willem M Greve
Nicole D Bouvy
Wim A Buurman
P2860
P304
P356
10.1371/JOURNAL.PONE.0110053
P407
P577
2014-10-09T00:00:00Z